The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Pharmacology of cannabinoid CB1 and CB2 receptors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Self-citationMolecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Self-citationDetermination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
Felder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., & Mitchell, R. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10492-6 · Cited by 869
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
Deutsch, D. G., & Chin, S. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90486-g · Cited by 702
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.
Mackie, K., & Hille, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3825 · Cited by 694
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 687
Mailleux, P., & Vanderhaeghen, J.-J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 664
Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D., & Leon, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3376 · Cited by 632
Mackie, K., Lai, Y., Westenbroek, R., & Mitchell, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06552.1995 · Cited by 626
Showalter, V. M., Compton, D. R., Martin, B. R., & Abood, M. E. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20744-3 · Cited by 571
Bouaboula, M., Poinot-Chazel, C., Bourrié, B., Canat, X., Calandra, B., Rinaldi-Carmona, M., Le Fur, G., & Casellas, P. (1995) · Biochemical Journal · doi:10.1042/bj3120637 · Cited by 543
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
Beal, J. E., Olson, R., Laubenstein, L., Morales, J. O., Bellman, P., Yangco, B., Lefkowitz, L., Plasse, T. F., & Shepard, K. V. (1995) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)00117-4 · Cited by 504
Hollister, L. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 497
Pharmacology of Cannabinoid Receptors
Howlett, A. C. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003135 · Cited by 488
Felder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K., & Devane, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7656 · Cited by 475
Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.
Howlett, A. C., Qualy, J. M., & Khachatrian, L. L. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10219-8 · Cited by 469
Compton, D. R., Rice, K. C., De Costa, B. R., Razdan, R. K., Melvin, L. S., Johnson, M. R., & Martin, B. R. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38122-x · Cited by 461
Sim, L. J., Selley, D. E., & Childers, S. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7242 · Cited by 455
Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
Fride, E., & Mechoulam, R. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90468-w · Cited by 451
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
Martin, B. R., Compton, D. R., Thomas, B. F., Prescott, W. R., Little, P. J., Razdan, R. K., Johnson, M. R., Melvin, L. S., Mechoulam, R., & Susan J., W. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90349-7 · Cited by 409
Howlett, A. C., & Fleming, R. M. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15066-9 · Cited by 375
Dewey, W. L. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90061-4 · Cited by 375
Structure-activity relationships in cannabinoids.
Razdan, R. K. (1986) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06863-2 · Cited by 370
Cannabinoid‐receptor expression in human leukocytes
BOUABOULA, M., RINALDI, M., CARAYON, P., CARILLON, C., DELPECH, B., SHIRE, D., LE FUR, G., & CASELLAS, P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17910.x · Cited by 367
Mackie, K., Devane, W. A., & Hille, B. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13215-x · Cited by 362
Compton, D. R., Aceto, M. D., Lowe, J., & Martin, B. R. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12911-x · Cited by 357
(R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability
Abadji, V., Lin, S., Taha, G., Griffin, G., Stevenson, L. A., Pertwee, R. G., & Makriyannis, A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00038a020 · Cited by 346
Self-citationIshac, E. J. N., Jiang, L., Lake, K. D., Varga, K., Abood, M. E., & Kunos, G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15639.x · Cited by 345
Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor
Hanus, L., Gopher, A., Almog, S., & Mechoulam, R. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00072a026 · Cited by 334
An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing
Shire, D., Carillon, C., Kaghad, M., Calandra, B., Rinaldi-Carmona, M., Fur, G. L., Caput, D., & Ferrara, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3726 · Cited by 330
Felder, C. C., Nielsen, A., Briley, E. M., Palkovits, M., Priller, J., Axelrod, J., Nguyen, D. N., Richardson, J. M., Riggin, R. M., Koppel, G. A., et al. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00891-5 · Cited by 326
Vogel, Z., Barg, J., Levy, R., Saya, D., Heldman, E., & Mechoulam, R. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03576.x · Cited by 300
Presence of cannabinoid binding sites in the brain from early postnatal ages
de Fonseca, F. R., Ramos, J. A., Bonnin, A., & Fernández-Ruiz, J. J. (1993) · NeuroReport · doi:10.1097/00001756-199302000-00005 · Cited by 297
Inverse agonism: pharmacological curiosity or potential therapeutic strategy?
Milligan, G., Bond, R. A., & Lee, M. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88963-4 · Cited by 287
Bouaboula, M., Poinot‐Chazel, C., Marchand, J., Canat, X., Bourrié, B., Rinaldi‐Carmona, M., Calandra, B., Le Fur, G., & Casellas, P. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0704p.x · Cited by 286
Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716
Terranova, J. P., Storme, J. J., Lafon, N., Pério, A., Rinaldi-Carmona, M., Le Fur, G., & Soubrié, P. (1996) · Psychopharmacology · doi:10.1007/bf02246352 · Cited by 283
Westlake, T. M., Howlett, A. C., Bonner, T. I., Matsuda, L. A., & Herkenham, M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90511-8 · Cited by 283
Caulfield, M. P., & Brown, D. A. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14321.x · Cited by 278
Lynn, A. B., & Herkenham, M. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38654-4 · Cited by 276
Design, Synthesis and Pharmacology of Cannabimimetic Indoles
Huffman, J. W., Dai, D., Martin, B. R., & Compton, D. R. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80155-4 · Cited by 275
Felder, C. C., Veluz, J. S., Williams, H. L., Briley, E. M., & Matsuda, L. A. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09174-6 · Cited by 261
Howlett, A. C. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12377-8 · Cited by 255
Howlett, A. C., Johnson, M. R., Melvin, L. S., & Milne, G. M. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13196-9 · Cited by 253
Kaminski, N. E., Abood, M. E., Kessler, F. K., Martin, B. R., & Schatz, A. R. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09130-8 · Cited by 248
Deadwyler, S. A., Hampson, R. E., Mu, J., Whyte, A., & Childers, S. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09495-9 · Cited by 241
Hillard, C. J., Wilkison, D. M., Edgemond, W. S., & Campbell, W. B. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00087-s · Cited by 233
Loss of cannabinoid receptors in the substantia nigra in huntington's disease
Glass, M., Faull, R. L. M., & Dragunow, M. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90352-g · Cited by 230
The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling
Bayewitch, M., Avidor-Reiss, T., Levy, R., Barg, J., Mechoulam, R., & Vogel, Z. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01207-u · Cited by 210
Cannabinoid Receptors and Modulation of Cyclic AMP Accumulation in the Rat Brain
Bidaut‐Russell, M., Devane, W. A., & Howlett, A. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08815.x · Cited by 208
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor
Shire, D., Calandra, B., Rinaldi-Carmona, M., Oustric, D., Pessègue, B., Bonnin-Cabanne, O., Le Fur, G., Caput, D., & Ferrara, P. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00047-4 · Cited by 208
Song, Z. H., & Bonner, T. I. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09082-0 · Cited by 206
A novel probe for the cannabinoid receptor
Devane, W. A., Breuer, A., Sheskin, T., Jaerbe, T. U. C., Eisen, M. S., & Mechoulam, R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00089a018 · Cited by 205
Inhibitors of arachidonoyl ethanolamide hydrolysis.
Koutek, B., Prestwich, G. D., Howlett, A. C., Chin, S. A., Salehani, D., Akhavan, N., & Deutsch, D. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31599-5 · Cited by 201
The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
Paria, B. C., Das, S. K., & Dey, S. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9460 · Cited by 200
Gifford, A. N., & Ashby, C. R. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13092-9 · Cited by 199
Di MARZO, V., De PETROCELLIS, L., SEPE, N., & BUONO, A. (1996) · Biochemical Journal · doi:10.1042/bj3160977 · Cited by 196
Shohami, E., Novikov, M., & Bass, R. (1995) · Brain Research · doi:10.1016/0006-8993(94)01433-i · Cited by 192
Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
Slipetz, D. M., O'Neill, G. P., Favreau, L., Dufresne, C., Gallant, M., Gareau, Y., Guay, D., Labelle, M., & Metters, K. M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10254-x · Cited by 191
Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons
Fan, P. (1995) · Journal of Neurophysiology · doi:10.1152/jn.1995.73.2.907 · Cited by 186
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker.
Feigenbaum, J. J., Bergmann, F., Richmond, S. A., Mechoulam, R., Nadler, V, Kloog, Y., & Sokolovsky, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9584 · Cited by 183
Oviedo, A., Glowa, J., & Herkenham, M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90220-h · Cited by 179
Cannabinoid ligand-receptor signaling in the mouse uterus.
Das, S. K., Paria, B. C., Chakraborty, I., & Dey, S. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4332 · Cited by 179
The central neuropharmcology of psychotropic cannabinoids
Pertwee, R. G. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90106-4 · Cited by 178
Self-citationRichfield, E. K., & Herkenham, M. (1994) · Annals of Neurology · doi:10.1002/ana.410360406 · Cited by 177
Effects of anandamide on cannabinoid receptors in rat brain membranes
Childers, S. R., Sexton, T., & Roy, M. B. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90134-1 · Cited by 176
Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells
Bouaboula, M., Bourrié, B., Rinaldi-Carmona, M., Shire, D., Fur, G. L., & Casellas, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13973 · Cited by 175
De Fonseca, F. R., Gorriti, M. A., Fernández-Ruiz, J. J., Palomo, T., & Ramos, J. A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90108-2 · Cited by 175
Henry, D. J., & Chavkin, C. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11289-9 · Cited by 173
Huffman, J. W., Yu, S., Showalter, V., Abood, M. E., Wiley, J. L., Compton, D. R., Martin, B. R., Bramblett, R. D., & Reggio, P. H. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960394y · Cited by 173
The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide
Wartmann, M., Campbell, D., Subramanian, A., Burstein, S. H., & Davis, R. J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00027-7 · Cited by 173
Santucci, V., Storme, J.-J., Soubrié, P., & Le Fur, G. (1996) · Life Sciences · doi:10.1016/0024-3205(95)02319-4 · Cited by 165
Kuster, J. E., Stevenson, J. I., Ward, S. J., D'Ambra, T. E., & Haycock, D. A. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10152-3 · Cited by 164
Further evidence for the presence of cannabinoid CB1 receptors in guinea‐pig small intestine
Pertwee, R. G., Fernando, S. R., Nash, J. E., & Coutts, A. A. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15663.x · Cited by 164
Self-citationCannabinoids modulate potassium current in cultured hippocampal neurons.
Deadwyler, S. A., Hampson, R. E., Bennett, B. A., Edwards, T. A., Mu, J., Pacheco, M. A., Ward, S. J., & Childers, S. R. (1993) · PubMed · Cited by 164
Pertwee, R. G., Stevenson, L. A., Elrick, D. B., Mechoulam, R., & Corbett, A. D. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09088.x · Cited by 159
Self-citationInhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds
Howlett, A. C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90278-9 · Cited by 156
AM630, a competitive cannabinoid receptor antagonist
Pertwee, R. G., Griffin, G., Fernando, S. R., Li, X., Hill, A., & Makriyannis, A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00175-6 · Cited by 154
Self-citationThe ontogeny of cannabinoid receptors in the brain of postnatal and aging rats
Belue, R. C., Howlett, A. C., Westlake, T. M., & Hutchings, D. E. (1995) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(94)00053-g · Cited by 153
Aminoalkylindoles: Structure-Activity Relationships of Novel Cannabinoid Mimetics
Eissenstat, M. A., Bell, M. R., D'Ambra, T. E., Alexander, E. J., Daum, S. J., Ackerman, J. H., Gruett, M. D., Kumar, V., & Estep, K. G. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00016a013 · Cited by 153
Nucleotide sequence of a human cannabinoid receptor cDNA
Gérard, C., Mollereau, C., Vassart, G., & Parmentier, M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.23.7142 · Cited by 152
Bayewitch, M. L., Rhee, M. H., Avidor‐Reiss, T., Breuer, A., Mechoulam, R., & Vogel, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9902 · Cited by 149
Differences in G-protein activation by μ- and δ-opioid, and cannabinoid, receptors in rat striatum
Sim, L. J., Selley, D. E., Xiao, R., & Childers, S. R. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00211-7 · Cited by 147
Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.
Pan, X., Ikeda, S. R., & Lewis, D. L. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08786-3 · Cited by 146
Lee, M., Yang, K. H., & Kaminski, N. E. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12097-1 · Cited by 144
Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein
Chakrabarti, A., Onaivi, E. S., & Chaudhuri, G. (1995) · DNA sequence · doi:10.3109/10425179509020870 · Cited by 140
Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles
Jansen, E. M., Haycock, D. A., Ward, S. J., & Seybold, V. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)90428-c · Cited by 139
Melvin, L. S., Milne, G. M., Johnson, M. R., Subramaniam, B., Wilken, G. H., & Howlett, A. C. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13256-2 · Cited by 136
Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs.
Adams, I. B., Ryan, W. J., Singer, M. M., Thomas, B. F., Compton, D. M., Razdan, R. K., & Martin, B. R. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09592-8 · Cited by 136
Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats
Mansbach, R. S., Rovetti, C. C., Winston, E., & Lowe, J. A., III (1996) · Psychopharmacology · doi:10.1007/bf02247436 · Cited by 135
Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication
Balster, R. L., & Prescott, W. R. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80051-x · Cited by 133
Condie, R. B., Herring, A. C., Koh, W. S., Lee, M., & Kaminski, N. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13175 · Cited by 133
Rinaldi, M. L., Pialot, F., Congy, C., Redon, E., Barth, F., Bachy, A., Brelière, J.-C., Soubrié, P., & Fur, G. L. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00085-9 · Cited by 132
Kaminski, N. E., Koh, W. S., Yang, K. H., Lee, M., & Kessler, F. K. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90588-6 · Cited by 132
Maneuf, Y. P., Nash, J. E., Crossman, A. R., & Brotchie, J. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00326-3 · Cited by 132
Hampson, A. J., Hill, W. A. G., Zan-Phillips, M., Makriyannis, A., Leung, E., Eglen, R. M., & Bornheim, L. M. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00157-8 · Cited by 131
Howlett, A. C., Champion, T. M., Wilken, G. H., & Mechoulam, R. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90056-w · Cited by 126
Wiley, J. L., Lowe, J. A., III, Balster, R. L., & Martin, B. R. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12022-3 · Cited by 126
Evidence for the presence of cannabinoid CB1receptors in mouse urinary bladder
Pertwee, R. G., & Fernando, S. R. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15643.x · Cited by 124
Self-citationMailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90832-r · Cited by 124
Aminoalkylindoles: actions on specific G-protein-linked receptors.
Pacheco, M., Childers, S. R., Arnold, R. A., Casiano, F. M., & Ward, S. J. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24755-3 · Cited by 124
Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats
Wiley, J. L., Barrett, R. L., Lowe, J. A., III, Balster, R. L., & Martin, B. R. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00027-4 · Cited by 122
Bramblett, R. D., Panu, A. M., Ballesteros, J. A., & Reggio, P. H. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00178-9 · Cited by 117
Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum
Herkenham, M. A., Groen, B. G. S., Lynn, A. B., Costa, B., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90096-e · Cited by 111
Selley, D. E., Stark, S., Sim, L. J., & Childers, S. R. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00347-5 · Cited by 111
Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors
Gareau, Y., Dufresne, C., Gallant, M., Rochette, C., Sawyer, N., Slipetz, D. M., Tremblay, N. M., WEECH, P. K., Metters, K. M., & Labelle, M. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00573-c · Cited by 110
Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
PINTO, J. C., Potié, F., Rice, K. C., Boring, D. L., Johnson, M. R., Evans, D. M., Wilken, G. H., Cantrell, C. H., & Howlett, A. C. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09729-9 · Cited by 109
1-Alkyl-3-(1-naphthoyl)pyrroles: A new class of cannabinoid
Lainton, J. A. H., Huffman, J. W., Martin, B. R., et al. (1995) · Tetrahedron Letters · doi:10.1016/0040-4039(95)00016-6 · Cited by 109
Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions
Marzo, V. D. (1995) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90123-x · Cited by 102
Romero, J., García‐García, L., Fernández‐Ruíz, J., Cebeira, M., & Ramos, J. A. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00023-p · Cited by 100
Howlett, A. C. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90035-9 · Cited by 98
Fan, F., Tao, Q., Abood, M. E., & Martin, B. R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01113-7 · Cited by 97
Shire, D. J., Calandra, B., Delpech, M., Dumont, X., Kaghad, M., Fur, G. L., Caput, D., & Ferrara, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6941 · Cited by 96
The evidence for the existence of cannabinoid receptors
Pertwee, R. G. (1993) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(93)90154-p · Cited by 95
Self-citationIdentification of cannabinoid receptors in cultures of rat cerebellar granule cells
Pacheco, M. A., Ward, S. J., & Childers, S. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91304-b · Cited by 94
Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain
Rubino, T., Massi, P., Patrini, G., Venier, I., Giagnoni, G., & Parolaro, D. (1994) · Neuroreport · doi:10.1097/00001756-199412000-00022 · Cited by 93
Abood, M. E., Sauss, C., Fan, F., Tilton, C. L., & Martin, B. R. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90546-6 · Cited by 85
Wright, C. E., & Angus, J. A. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15676.x · Cited by 83
Hillard, C. J., Edgemond, W. S., & Campbell, W. B. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020677.x · Cited by 82
Structural Requirements for Cannabinoid Receptor Probes
Thakur, G. A., Nikas, S. P., Li, C., & Makriyannis, A. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_7 · Cited by 79
Pertwee, R. G., Fernando, S. R., Griffin, G., Abadji, V., & Makriyannis, A. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00618-h · Cited by 79
Self-citationSelley, D. E., Breivogel, C. S., & Childers, S. R. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13250-1 · Cited by 78
Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.
Fride, E., Barg, J., Levy, R., Saya, D., Heldman, E., Mechoulam, R., & Vogel, Z. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24465-2 · Cited by 75
Neurobehavioral effects of Δ9-THC and cannabinoid (CB1) receptor gene expression in mice
Onaivi, E. S., Chakrabarti, A., Gwebu, E. T., & Chaudhuri, G. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00139-8 · Cited by 75
Shivachar, A. C., Martin, B. R., & Ellis, E. F. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(95)02248-1 · Cited by 74
Discriminative stimulus effects of anandamide in rats
Wiley, J. L., Balster, R. L., & Martin, B. R. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00010-i · Cited by 74
Waterman, S. A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-13-04155.1996 · Cited by 72
Wiley, J. L., Huffman, J. W., Balster, R. L., & Martin, B. R. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01193-5 · Cited by 70
Pharmacological specificity of Δ9-tetrahydrocannabinol discrimination in rats
Barrett, R. L., Wiley, J. L., Balster, R. L., et al. (1995) · Psychopharmacology · doi:10.1007/bf02245942 · Cited by 68
Central mediation of the cannabinoid cue
P??rio, A., Rinaldi, M. L., Maruani, J., Barth, F., Fur, G. L., & Soubri??, P. (1996) · Behavioural Pharmacology · doi:10.1097/00008877-199601000-00006 · Cited by 68
Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation.
Daaka, Y., Friedman, H. P., & Klein, T. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12361-6 · Cited by 67
Pertwee, R. G., Griffin, G., Lainton, J. A. H., & Huffman, J. W. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00318-f · Cited by 67
Self-citationBarg, J., Fride, E., Hanus, L. O., Levy, R., Matus-Leibovitch, N., Heldman, E., Bayewitch, M. L., Mechoulam, R., & Vogel, Z. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00487-4 · Cited by 67
Reche, I., Fuentes, J. A., & Ruiz‐Gayo, M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00045-3 · Cited by 64
Cannabinoid Receptor‐Regulated Cyclic AMP Accumulation in the Rat Striatum
Bidaut‐Russell, M., & Hewlett, A. C. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06379.x · Cited by 64
The Conformational Properties of the Highly Selective Cannabinoid Receptor Ligand CP-55,940
Xie, X., Melvin, L. S., & Makriyannis, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10640 · Cited by 64
Priller, J., Briley, E. M., Mansouri, J., Devane, W. A., Mackie, K., & Felder, C. C. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10247-2 · Cited by 64
Gold, L. H., Balster, R. L., Barrett, R. L., et al. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10783-0 · Cited by 62
Thomas, B. F., Wei, X., & Martin, B. R. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10481-3 · Cited by 61
Cannabinoid receptors in developing rats: detection of mRNA and receptor binding
McLaughlin, C., Martin, B. R., Compton, D. R., & Abood, M. E. (1994) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)90006-x · Cited by 56
Onaivi, E. S., Chakrabarti, A. K., & Chaudhuri, G. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00044-5 · Cited by 55
Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentia
Pertwee, R. G., Griffin, G., Hanus, L. O., & Mechoulam, R. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90499-5 · Cited by 54
Self-citationPertwee, R. G., Fernando, S. R., Griffin, G., Ryan, W. J., Razdan, R. K., Compton, D. M., & Martin, B. R. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00631-0 · Cited by 46
Self-citationSchatz, A. R., Kessler, F. K., & Kaminski, N. E. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90414-k · Cited by 46
Molecular Mechanisms of Toxicant-Induced Immunosuppression: Role of Second Messengers
Holsapple, M. P., Karras, J. G., Ledbetter, J. A., Schieven, G. L., Burchiel, S. W., Davila, D. R., Shatz, A. R., & Kaminski, N. E. (1996) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001023 · Cited by 45
Tolerance to and dependence on psychotropic cannabinoids
Pertwee, R. G. (1992) · Cited by 38
Self-citationMartin, B. R. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)01081-u · Cited by 37
Houston, D. B., & Howlett, A. C. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13413-5 · Cited by 37
Biochemical and pharmacological characterization of cannabinoid binding sites using [3H]SR141716A
Petitet, F., Marin, L., & Doble, A. (1996) · Neuroreport · doi:10.1097/00001756-199602290-00026 · Cited by 36
Pacheco, M. A., Ward, S. J., & Childers, S. R. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62051773.x · Cited by 34
Studies on lidocaine-induced kindling
Dorris, R. L., & Lotzof, L. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90214-a · Cited by 33
Cannabinoid Geometry and Biological Activity
Mechoulam, R., Devane, W. A., & Glaser, R. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_9 · Cited by 30
Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization.
Evans, D. M., Lake, J. T., Johnson, M. R., et al. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38621-0 · Cited by 27
Structural requirements for cannabinoid receptor probes
Razdan, R. K., Thomas, B. F., & Martin, B. R. (1994) · Cited by 25
Recent Developments Cannabinoids in the Medicinal Chemistry of Cannabinoids
Huffman, J. W., & Lainton, J. A. H. (1996) · Current Medicinal Chemistry · doi:10.2174/092986730302220302094839 · Cited by 24
The Discovery of Nonclassical Cannabinoid Analgetics
Johnson, M. R., & Melvin, L. S. (2019) · Chapman & Hall/CRC eBooks · doi:10.1201/9780429260667-7 · Cited by 22
Expression of a cannabinoid receptor in baculo virus-infected insect cells
Pettit, D. A. D., Showalter, V. M., Abood, M. E., & Cabral, G. A. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90161-9 · Cited by 20
Mailleux, P., Verslijpe, M., & Vanderhaeghen, J. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90845-x · Cited by 20
Ho, B. Y., & Zhao, J. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12792-0 · Cited by 20
Pugh, G., Welch, S. P., & Bass, P. P. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90270-4 · Cited by 14
Turkanis, S. A., Karler, R., & Partlow, L. M. (1991) · Brain Research · doi:10.1016/0006-8993(91)91239-w · Cited by 13
Järbe, T. U. C., Hiltunen, A. J., Mathis, D. A., Hanus, L. O., Breuer, A., & Mechoulam, R. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10177-8 · Cited by 5
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationVanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Pertwee, R. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,935
Self-citationThe orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
“The finding that cannabidiol is an antagonist of GPR55 is interesting since until recently (Thomas et al., 2007) it has not been shown to have any significant effect on CB1 and CB2 receptor signalling (Pertwee, 1997), as confirmed by our studies (Table 1).”
BackgroundResult
Metadata
- Authors
- Pertwee, R. G.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 1997-01
- Volume
- 74
- Issue
- 2
- Pages
- 129-180
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2015614945
- Cited by
- 1,470
- References
- 173
- FWCI
- 36.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.